These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1516877)

  • 21. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K; Abb J; Farack UM; Wiebecke B
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
    Besirbellioglu B; Gul C; Gorenek L; Eyigun CP; Hacibektasoglu A; Van Thiel DH
    Hepatogastroenterology; 1999; 46(25):387-90. PubMed ID: 10228827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intramuscular natural beta interferon in the treatment of chronic hepatitis B: a multicentre trial. Italian Hepatitis B Study Group.
    Capalbo M; Palmisano L; Bonino F; Pellas C; Maset J
    Ital J Gastroenterol; 1994 Jun; 26(5):238-41. PubMed ID: 7919465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
    Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of clinical effectiveness of colchicine in the treatment of chronic active hepatitis with transformation to liver cirrhosis].
    Simon K; Gładysz A; Zalewska M; Machaj A
    Przegl Epidemiol; 1991; 45(4):331-4. PubMed ID: 1841412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adenine arabinoside: hope in the treatment of chronic virus B hepatitis].
    Guerre J; Gaudric M; Couturier D; Levy C
    Presse Med; 1983 Mar; 12(12):743-6. PubMed ID: 6220311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
    Hayashi J; Kajiyama W; Noguchi A; Nakashima K; Hirata M; Hayashi S; Kashiwagi S
    Gastroenterol Jpn; 1991 Dec; 26(6):742-6. PubMed ID: 1765247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive).
    Sumiyama K; Kobayashi M; Miyashiro E; Koike M
    Acta Paediatr Jpn; 1991 Jun; 33(3):327-34. PubMed ID: 1785328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of chronic hepatitis other than interferon therapy].
    Sainokami S; Hino K; Niwa H
    Nihon Naika Gakkai Zasshi; 1994 Feb; 83(2):235-9. PubMed ID: 7963944
    [No Abstract]   [Full Text] [Related]  

  • 32. Isoprinosine in the treatment of chronic active hepatitis type B.
    Cianciara J; Laskus T; Gabinska E; Loch T
    Scand J Infect Dis; 1990; 22(6):645-8. PubMed ID: 1704640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.
    Takahara T; Watanabe A; Shiraki K
    J Hepatol; 1994 Oct; 21(4):601-9. PubMed ID: 7814808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
    Su XS; Chen HM; Wang LH; Jiang CF; Liu JH; Zhao MQ; Ma XH; Zhao YC; Han DW
    J Tradit Chin Med; 1984 Jun; 4(2):127-32. PubMed ID: 6567725
    [No Abstract]   [Full Text] [Related]  

  • 36. Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis.
    Nishimura K; Ishizaka S; Tsujii T
    Biotherapy; 1992; 4(4):299-306. PubMed ID: 1622743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic basis of glycyrrhizin on chronic hepatitis B.
    Sato H; Goto W; Yamamura J; Kurokawa M; Kageyama S; Takahara T; Watanabe A; Shiraki K
    Antiviral Res; 1996 May; 30(2-3):171-7. PubMed ID: 8783808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
    Tokita H; Shimizu M; Takahashi Y; Tanaka H; Yasuda M; Kojima M; Adachi N; Yoshida H
    Nihon Shokakibyo Gakkai Zasshi; 1987 Dec; 84(12):2706-13. PubMed ID: 3450885
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].
    Sodomann CP; Maerker-Alzer G; Havemann K; Dienst C; Schultz H; Mitrenga D; Schumacher K; Martini GA
    Klin Wochenschr; 1979 Sep; 57(17):893-903. PubMed ID: 388053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A double-blind study of strong neominophagen-C in treating chronic hepatitis].
    Wang JT
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):14-8, 62. PubMed ID: 6396046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.